Esperion Therapeutics has agreed to buy fellow biopharmaceutical company Corstasis Therapeutics and its Enbumyst nasal-spray product, for an initial $75 million in cash. Esperion on Tuesday said ...
NASA has severe penalties for those who dare to deal in astromaterials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results